The role of C-reactive protein in modern obstetric and gynecological practice

References

• Tillett WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of the pneumococcus. J Exp Med 1930; 52: 561–71
   PubMedGoogle Scholar
• Abernathy TJ, Avery OT. The occurrence during acute infection of a protein not normally present in the blood. I. Distribution of the reactive protein in patients’ sera and the effects of calcium on the flocculation reaction with C polysaccharide of pneumococcus. J Exp Med 1941; 73: 173
   PubMedGoogle Scholar
• MacLeod CM, Avery OT. The occurrence during acute infections of a protein not normally present in blood. II. Isolation and properties of the C-reactive protein. J Exp Med 1941; 73: 183
   PubMedGoogle Scholar
• Ballou SP, Kushner I. C-reactive protein and the acute phase response. Adv Intern Med 1992; 37: 313–36
   PubMedGoogle Scholar
• Gambino R. C-reactive protein – undervalued, underutilized. Clin Chem 1997; 43(11)2017–8
   PubMed Web of Science ®Google Scholar
• Gotschlich EC. C-reactive protein. A historical overview. Ann N Y Acad Sci 1989; 557: 9–18
   PubMed Web of Science ®Google Scholar
• Kolb-Bachofen V. A review on the biological properties of C-reactive protein. Immunobiology 1991; 183: 133–45
   PubMed Web of Science ®Google Scholar
• Pepys MB. C-reactive protein fifty years on. Lancet 1981; 1: 653–7
   PubMed Web of Science ®Google Scholar
• Palosuo T, Husman T, Koistinen J, Aho K. C-reactive protein in population samples. Acta Med Scand 1986; 220: 175–9
   PubMedGoogle Scholar
• Jaye DL, Waites KB. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J 1997; 16: 735–47
   PubMed Web of Science ®Google Scholar
• International Committee for Standardization in Haematology. Guidelines on selection of laboratory tests for monitoring the acute phase response. J Clin Pathol 1988; 41: 1203–12.
   PubMed Web of Science ®Google Scholar
• Deodar SD. C-reactive protein: the best laboratory indicator available for monitoring disease activity. Cleve Clin J Med 1989; 56: 126–30
   PubMed Web of Science ®Google Scholar
• Stuart J, Whicher JT. Tests for detecting and monitoring the acute phase response. Arch Dis Child 1988; 63: 115–7
   PubMed Web of Science ®Google Scholar
• Okamura JM, Miyagi JM, Terada K, Hokama Y. Potential clinical applications of C-reactive protein. J Clin Lab Anal 1990; 4: 231–5
   PubMed Web of Science ®Google Scholar
• Sanchez A, Mirabel JL, Barrenechea E, Eugui J, Puelles A, Castaneda A. Evaluation of an improved immunoturbidimetic assay for serum C-reactive protein on a COBAS INTEGRA 400 Analyzer. Clin Lab 2002; 48(5–6)313–7
   PubMedGoogle Scholar
• Van Lente F, Marchand A, Galen RS. Evaluation of the nephelometric assay of CRP using the Beckman ICS. Clin Chem 1981; 27: 1075
   Web of Science ®Google Scholar
• Jupe D. The acute phase response and laboratory testing. Aust Fam Phys 1996; 25: 324–9
   PubMedGoogle Scholar
• Harmoinen A, Hallstrom O, Gronroos P. Rapid quantitative determination of C-reactive protein using laser nephelometer. Scand J Clin Lab Invest 1980; 40: 293
   PubMed Web of Science ®Google Scholar
• Loukovaara MJ, Alfthan HV, Kurki MT, Hiilesmaa VK, Andersson SH. Serum highly sensitive C-reactive protein in preterm premature rupture of membranes. Eur J Obstet Gynecol Reprod Biol 2003; 110(1)26–8
   PubMed Web of Science ®Google Scholar
• Young B, Gleeson M, Cripps AW. C-reactive protein: a critical review. Pathology 1991; 23: 118–24
   PubMed Web of Science ®Google Scholar
• Gibbs RS, Blanco JD. Premature rupture of the membranes. Obstet Gynecol 1982; 60(6)671–9
   PubMed Web of Science ®Google Scholar
• Kurki T, Teramo K, Ylikorkala O, Paavonen J. C-reactive protein in preterm premature rupture of the membranes. Arch Gynecol Obstet 1990; 247(1)31–7
   PubMed Web of Science ®Google Scholar
• Nowak M, Oszukowski P, Szpakowski M, Malinowski A, Maciolek-Blewniewska G. Intrauterine infections. I. The role of C-reactive protein, white blood cell count and erythrocyte sedimentation rate in pregnant women in the detection of intrauterine infection after preliminary rupture of membranes]. Ginekol Pol 1998; 69(8)615–22
   PubMedGoogle Scholar
• Evans MI, Hajj SN, Devoe LD, Angerman NS, Moawad AH. C-reactive protein as a predictor of infectious morbidity with premature rupture of membranes. Am J Obstet Gynecol 1980; 138(6)648–52
   PubMed Web of Science ®Google Scholar
• Ismail MA, Zinaman MJ, Lowensohn RI, Moawad AH. The significance of C-reactive protein levels in women with premature rupture of membranes. Am J Obstet Gynecol 1985; 151(4)541–4
   PubMed Web of Science ®Google Scholar
• Awara AM, Marei SK, Elghorab NM, Elnewahy MA, Aboulenin AA. Predictive value of C-reactive protein in serum of maternal and cord blood in cases with premature rupture of membranes. Egypt Med J 1992; 9(2)31–7
   PubMedGoogle Scholar
• Fisk NM, Fysh J, Child AG, Gatenby PA, Jeffery H, Bradfield AH. Is C-reactive protein really useful in preterm premature rupture of the membranes?. Br J Obstet Gynaecol 1987; 94(12)1159–64
   PubMedGoogle Scholar
• Saini S, Goel N, Sharma M, Arora B, Garg N. C-reactive proteins as an indicator of sub-clinical infection in cases of premature rupture of membranes. Indian J Pathol Microbiol 2003; 46(3)515–6
   PubMedGoogle Scholar
• Sereepapong W, Limpongsanurak S, Triratanachat S, Wannakrairot P, Charuruks N, Krailadsiri P. The role of maternal serum C-reactive protein and white blood cell count in the prediction of chorioamnionitis in women with premature rupture of membranes. J Med Assoc Thai 2001; 84(Suppl 1)S360–6
   PubMedGoogle Scholar
• Romem Y, Artal R. C-reactive protein as a predictor for chorioamnionitis in cases of premature rupture of the membranes. Am J Obstet Gynecol 1984; 150(5 Pt 1)546–50
   PubMed Web of Science ®Google Scholar
• Hawrylyshyn P, Bernstein P, Milligan JE, Soldin S, Pollard A, Papsin FR. Premature rupture of membranes: the role of C-reactive protein in the prediction of chorioamnionitis. Am J Obstet Gynecol 1983; 147(3)240–6
   PubMed Web of Science ®Google Scholar
• Di Naro E, Ghezzi F, Raio L, Romano F, Mueller MD, McDougall J, Cicinelli E. C-reactive protein in vaginal fluid of patients with preterm premature rupture of membranes. Acta Obstet Gynecol Scand 2003; 82(12)1072–9
   PubMed Web of Science ®Google Scholar
• Hirsch W, Koppitz D, Morack G, Gerhardt C. C-reactive protein in the maternal serum and risk of fetal infection in premature rupture of the fetal membranes and threatened premature labor]. Zentralbl Gynakol 1989; 111(21)1411–6
   PubMedGoogle Scholar
• de Souza JJ, Perlmann T, Herman AA, Ransome OJ, Kantor RW. C-reactive protein as a predictor of fetal and maternal infective morbidity and fetal mortality. S Afr Med J 1987; 71(11)690–2
   PubMed Web of Science ®Google Scholar
• Rush RW, Kierse MJNC, Howat P. Contribution of preterm delivery to perinatal mortality. BMJ 1976; 2: 965–8
   PubMed Web of Science ®Google Scholar
• Lamont RF. The role of infection in preterm labour and birth. Hosp Med 2003; 64(11)644–7
   PubMedGoogle Scholar
• Friese K. The role of infection in preterm labour. BJOG 2003; 110(Suppl 20)52–4
   PubMedGoogle Scholar
• Radnai M, Gorzo II, Nagy E, Urban E, Novak T, Pal A. A possible association between preterm birth and early periodontitis. J Clin Periodontol 2004; 31(9)736–41
   PubMed Web of Science ®Google Scholar
• Leitich H, Bodner-Adler B, Brunbauer M, Kaider A, Egarter C, Husslein P. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol 2003; 189(1)139–47
   PubMed Web of Science ®Google Scholar
• Cammu H, Goossens A, Derde MP, Temmerman M, Foulon W, Amy JJ. C-reactive protein in preterm labour: association with outcome of tocolysis and placental histology. Br J Obstet Gynaecol 1989; 96(3)314–9
   PubMedGoogle Scholar
• Mazor M, Kassis A, Horowitz S, Wiznitzer A, Kuperman O, Meril C, et al. Relationship between C-reactive protein levels and intraamniotic infection in women with preterm labor. J Reprod Med 1993; 38(10)799–803
   PubMed Web of Science ®Google Scholar
• Watts DH, Krohn MA, Hillier SL, Wener MH, Kiviat NB, Eschenbach DA. Characteristics of women in preterm labor associated with elevated C-reactive protein levels. Obstet Gynecol 1993; 82(4 Pt 1)509
   PubMed Web of Science ®Google Scholar
• Mazor M, Zitzer P, Chaim W, Maymon E, Kuperman O. C-reactive protein as a marker of infection in women with preterm delivery]. Harefuah 1993; 124(3)132–7, 183–4
   PubMedGoogle Scholar
• Potkul RK, Moawad AH, Ponto KL. The association of subclinical infection with preterm labor: the role of C-reactive protein. Am J Obstet Gynecol 1985; 153(6)642–5
   PubMed Web of Science ®Google Scholar
• Winkler M, Gellings R, Putz I, Funk A, Goetz M. Puerperium after threatened premature labor – positive effects of infection screening by determination of CRP in pregnancy]. Zentralbl Gynakol 1994; 116(10)555–60
   PubMedGoogle Scholar
• Hvilsom GB, Thorsen P, Jeune B, Bakketeig LS. C-reactive protein: a serological marker for preterm delivery?. Acta Obstet Gynecol Scand 2002; 81(5)424–9
   PubMed Web of Science ®Google Scholar
• Ghezzi F, Franchi M, Raio L, Di Naro E, Bossi G, D'Eril GV, et al. Elevated amniotic fluid C-reactive protein at the time of genetic amniocentesis is a marker for preterm delivery. Am J Obstet Gynecol 2002; 186(2)268–73
   PubMed Web of Science ®Google Scholar
• Kenyon, S, Boulvain, M, Neilson, J. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 2003, 2: CD001058.
   PubMedGoogle Scholar
• Bollen B, Padwick M. Delayed delivery of second twin after chorioamnionitis and abortion of first twin at 21 weeks gestation. Eur J Obstet Gynecol Reprod Biol 2000; 93(1)109–10
   PubMed Web of Science ®Google Scholar
• Soper DE. Diagnosis and laparoscopic grading of acute salpingitis. Am J Obstet Gynecol 1991; 164: 1370–6
   PubMed Web of Science ®Google Scholar
• Miettinen AK, Heinonen PK, Laippala P, Paavonen J. Test performance of erythrocyte sedimentation rate and C-reactive protein in assessing the severity of acute pelvic inflammatory disease. Am J Obstet Gynecol 1993; 169(5)1143–9
   PubMed Web of Science ®Google Scholar
• Lehtinen M, Laine S, Heinonen PK, Teisala K, Miettinen A, Aine R, et al. Serum C-reactive protein determination in acute pelvic inflammatory disease. Am J Obstet Gynecol 1986; 154: 158–9
   PubMed Web of Science ®Google Scholar
• Reljic M, Gorisek B. C-reactive protein and the treatment of pelvic inflammatory disease. Int J Gynaecol Obstet 1998; 60(2)143–50
   PubMed Web of Science ®Google Scholar
• Schmidt-Rhode P, Schulz KD, Sturm G, Prinz H. C-reactive protein is a marker for the diagnosis of adnexitis. Int J Gynaecol Obstet 1990; 32(2)133–9
   PubMed Web of Science ®Google Scholar
• Teisala K, Heinonen PK. C-reactive protein in assessing antimicrobial treatment of acute pelvic inflammatory disease. J Reprod Med 1990; 35(10)955–8
   PubMed Web of Science ®Google Scholar
• Jodal U, Lindberg U, Lincoln K. Level diagnosis of symptomatic urinary tract infections in childhood. Acta Paediatr Scand 1975; 64: 201–8
   PubMed Web of Science ®Google Scholar
• Hellerstein S, Duggan E, Welchert E, Mansour F. Serum C-reactive protein and the site of urinary tract infections. J Pediatr 1982; 100: 21–5
   PubMed Web of Science ®Google Scholar
• Sandberg T, Lidin-Janson G, Eden CS. Host response in women with symptomatic urinary tract infection. Scand J Infect Dis 1989; 21(1)67–73
   PubMed Web of Science ®Google Scholar
• Chase HP, Cooper S, Osberg I, Stene LC, Barriga K, Norris J, et al. Elevated C-reactive protein levels in the development of type 1 diabetes. Diabetes 2004; 53(10)2569–73
   PubMed Web of Science ®Google Scholar
• Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004; 53(3)693–700
   PubMed Web of Science ®Google Scholar
• Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 2003; 26(3)819–24
   PubMed Web of Science ®Google Scholar
• Qiu C, Sorensen TK, Luthy DA, Williams MA. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus. Paediatr Perinat Epidemiol 2004; 18(5)377–84
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware RL. Hormone therapy and the cardiovascular system: the critical role of progestins. Climacteric 2003; 6(Suppl 3)21–8
   PubMedGoogle Scholar
• Yudkin, JS, Juhan-Vague, I, Hawe, E, Humphries, SE, di Minno, G, Margaglione, M, et al; The HIFMECH Study Group. Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism 2004;53((7)):852–7.
   PubMed Web of Science ®Google Scholar
• Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004; 109(21 Suppl 1)II2–10
   PubMed Web of Science ®Google Scholar
• Skouby SO, Gram J, Andersen LF, Sidelmann J, Petersen KR, Jespersen J. Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations. Am J Obstet Gynecol 2002; 186(5)969–77
   PubMed Web of Science ®Google Scholar
• Williams MJ, Williams SM, Milne BJ, Hancox RJ, Poulton R. Association between C-reactive protein, metabolic cardiovascular risk factors, obesity and oral contraceptive use in young adults. Int J Obes Relat Metab Disord 2004; 28(8)998–1003
   PubMed Web of Science ®Google Scholar
• Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998; 179(1)80–6
   PubMed Web of Science ®Google Scholar
• Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180(2 Pt 1)499–506
   PubMed Web of Science ®Google Scholar
• Sacks GP, Seyani L, Lavery S, Trew G. Maternal C-reactive protein levels are raised at 4 weeks gestation. Hum Reprod 2004; 19(4)1025–30
   PubMed Web of Science ®Google Scholar
• Qiu C, Luthy DA, Zhang C, Walsh SW, Leisenring WM, Williams MA. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am J Hypertens 2004; 17(2)154–60
   PubMed Web of Science ®Google Scholar
• Tjoa ML, van Vugt JM, Go AT, Blankenstein MA, Oudejans CB, van Wijk IJ. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol 2003; 59(1)29–37
   PubMed Web of Science ®Google Scholar
• Wolf M, Kettyle E, Sandler L, Ecker JL, Roberts J, Thadhani R. Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol 2001; 98(5 Pt 1)757–62
   PubMed Web of Science ®Google Scholar
• Teran E, Escudero C, Moya W, Flores M, Vallance P, Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia. Int J Gynaecol Obstet 2001; 75(3)243–9
   PubMed Web of Science ®Google Scholar
• Belo L, Santos-Silva A, Caslake M, Cooney J, Pereira-Leite L, Quintanilha A, et al. Neutrophil activation and C-reactive protein concentration in preeclampsia. Hypertens Pregnancy 2003; 22(2)129–41
   PubMed Web of Science ®Google Scholar
• Hallan S, Asberg A. The accuracy of C-reactive protein in diagnosing acute appendicitis – a meta-analysis. Scand J Clin Lab Invest 1997; 57: 373–80
   PubMed Web of Science ®Google Scholar
• Erkasap S, Ates E, Ustuner Z, Sahin A, Yilmaz S, Yasar B, et al. Diagnostic value of interleukin-6 and C-reactive protein in acute appendicitis. Swiss Surg 2000; 6(4)169–72
   PubMedGoogle Scholar
• Juvonen T, Kiviniemi H, Niemela O, Kairaluoma MI. Diagnostic accuracy of ultrasonography and C-reactive protein concentration in acute cholecystitis: a prospective clinical study. Eur J Surg 1992; 158: 365–9
   PubMedGoogle Scholar
• Sternby B, O'Brien JF, Zinsmeister AR, DiMagno EP. What is the best biochemical test to diagnose acute pancreatitis? A prospective clinical study. Mayo Clin Proc 1996; 71: 1138–44
   PubMed Web of Science ®Google Scholar
• Gadducci A, Ferdeghini M, Prontera C, Moretti L, Mariani G, Bianchi R, et al. The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis. Gynecol Oncol 1992; 44(2)147–54
   PubMed Web of Science ®Google Scholar
• Palmer, A, Carlin, JB, Freihorst, J, Gatchalian, S, Muhe, L, Mulholland, K, et al; WHO Young Infant Study Group. The use of CRP for diagnosing infections in young infants <3 months of age in developing countries. Ann Trop Paediatr 2004; 24((3)): 205–12.
   PubMedGoogle Scholar
• Povoa P, Almeida E, Moreira P, Fernandes A, Mealha R, Aragao A, et al. C-reactive protein as an indicator of sepsis. Intensive Care Med 1998; 24(10)1052–6
   PubMed Web of Science ®Google Scholar
• Borrelli PT, Butler SA, Docherty SM, Staite EM, Borrelli AL, Iles RK. Human chorionic gonadotropin isoforms in the diagnosis of ectopic pregnancy. Clin Chem 2003; 49(12)2045–9
   PubMed Web of Science ®Google Scholar
• Mora J, Gascon N, Tabernero JM, Germa JR, Gonzalez F. Alpha-fetoprotein-concanavalin A binding as a marker to discriminate between germ cell tumours and liver diseases. Eur J Cancer 1995; 31A(13–14)2239–42
   PubMed Web of Science ®Google Scholar